论文部分内容阅读
目的观察中药透皮给药佐治小儿肺炎支原体肺炎风热闭肺证的临床疗效。方法将符合纳入标准的80例肺炎支原体肺炎风热闭肺证患儿随机分为对照组和治疗组,各40例。对照组给予西医常规治疗,治疗组在对照组治疗方法的基础上给予中药透皮给药,治疗7 d后观察2组患儿的临床疗效。结果治疗组体温恢复正常时间、肺部啰音消失时间以及住院时间均短于对照组,经统计分析,差异均有高度统计意义(P<0.01);治疗组总有效率为100.0%,对照组为90.0%,2组总有效率经统计学分析,差异有统计意义(P<0.05)。结论中药透皮给药佐治小儿肺炎支原体肺炎风热闭肺证疗效明显优于单纯西医治疗,值得临床推广应用。
Objective To observe the clinical effect of transdermal administration of traditional Chinese medicine on children with pneumonia and mycoplasma pneumonia. Methods A total of 80 cases of Mycoplasma pneumoniae pneumonia with pneumoconiosis and lungs syndrome, which met the inclusion criteria, were randomly divided into control group and treatment group, 40 cases in each group. The control group was given conventional treatment of Western medicine. The treatment group was given transdermal drug delivery on the basis of the control group. After 7 days of treatment, the clinical efficacy of the two groups was observed. Results The body temperature recovery time, the time of pulmonary rales disappearance and hospital stay were shorter in the treatment group than in the control group, and the difference was statistically significant (P <0.01). The total effective rate was 100.0% in the control group Was 90.0%. The total effective rate of the two groups was statistically analyzed, the difference was statistically significant (P <0.05). Conclusion Chinese medicine transdermal administration of adjuvant treatment of children with Mycoplasma pneumoniae pneumonia Fengfei Closed lung syndrome was significantly better than the treatment of Western medicine, it is worthy of clinical application.